When:

Sunday 12 November
8.30am – 4.30pm

Cost:

Free for full conference registrants

Presenters:

TBC

Overview:

People who inject drugs represent approximately 90% of newly acquired hepatitis C infections. Clinicians in primary care and drug and alcohol settings play an important role in improving the health outcomes of people living with hepatitis C and can reduce a patient’s risk of developing advanced liver disease through early diagnosis, appropriate management of co-morbidities and treatment with new, curative, Direct Acting Antiviral medication (DAAs).

This interactive course is designed to strengthen the capacity of clinical staff working in primary care or drug and alcohol settings to effectively test for, treat and manage hepatitis C.

The online learning and face-to-face workshop will give you the skills to confidently prescribe the new Direct Acting Antiviral (DAA) medications for hepatitis C.

This course is free. Registration is essential. Lunch and refreshments will be provided.

This activity has been approved by the RACGP QI&CPD Program for 40 Category 1 CPD points, and by ACRRM for 30 PRPD points.

This workshop has been supported through an undconditional grant from Gilead Sciences Pty Ltd.

When:

Sunday 12 November
10.00am - 12.30pm

Cost:

Free for full conference registrants

Presenter:

Professor Amanda Baker University of Newcastle

Professor Billie Bonevski  University of Newcastle

Assoc Prof Peter Kelly University of Wollongong

Dr Donita Baird Quit Victoria Cancer Council Victoria

Dr Cathy Segan Quit Victoria Cancer Council Victoria

Dr Victoria Manning Turning Point  Melbourne

Ms Melissa Jackson University of Newcastle

Overview:

The aim of the workshop is to support smoking cessation in alcohol and other drug (AOD) services. In Australia, up to 95% of people entering AOD treatment smoke tobacco. In addition, people often present for treatment displaying multiple substance abuse, mental health, and/or physical health problems. Recently, there have been a number of exciting developments in addressing smoking cessation and comorbidity among people attending AOD services. In this practically focused workshop, leading clinicians and researchers will present results from recent literature reviews and treatment trials, and describe new trials in progress.

Participants’ knowledge and skills will be improved in the following areas:

·        The effectiveness of addressing smoking in AOD settings (Overview by Amanda Baker).

·        A 3 step brief intervention for smoking cessation that can be integrated into AOD services (Donita Baird and Cathy Segan).  

·        Conducting Healthy Lifestyle interventions (Peter Kelly).

·        Addressing smoking in pregnant women attending substance use services: overview and the iQuiP trial (Melissa Jackson).

·        QuitNic: A pilot study comparing standard nicotine replacement therapy and electronic cigarettes for smoking cessation upon client discharge from a smoke-free drug and alcohol detox unit (Billie Bonevski and Victoria Manning).

Interactive exercises will be undertaken focusing on key elements of assessment and intervention.  

When:

Sunday 12 November
1.00pm – 4.00pm

Cost:

Free for full conference registrants

Please note only RACP members can attend this workshop

Presenter:

A/Prof Kees Nydam

Overview:

Teaching and Learning in Healthcare Settings provides a range of teaching strategies to manage and overcome challenges supervisors face in a complex healthcare setting. These strategies include planning for learning, differentiated instructions for multi-level groups, and using teaching techniques such as questioning. This workshop explores some cultural aspects that may impact on learning and the need for effective role modelling.

Objectives:

·        Outline the challenges supervisors face in the healthcare setting

·        Identify the strategies supervisors can use to maximise teaching opportunities

·        Evaluate personal attitudes, beliefs and behaviour and its influence on supervisory practice

·        Assess workplace culture issues that can affect education experiences

When:

Sunday 12 November
1.30pm – 4.40pm

Cost:

Free for members*
$30 non-members

Overview:

Publishing Discussion: 1:30pm - 3:30pm

Professor Paul Dietze, Executive Editor Drug and Alcohol Review The purpose of this Workshop is to equip early career researchers (ECR) with the skills and know-how to successfully publish peer-reviewed articles in alcohol and other drug (AOD) research and policy relevant journals. The Workshop will be relevant for ECRs engaged in both quantitative and qualitative research.

The Publishing Workshop will follow the journey of a paper from submission to publication, including discussion of: the kinds of papers that journals are currently seeking and how authors should try to orient their papers accordingly; editorial processes; responding to reviewers and revisions; and final product. Case examples will be used by the facilitators to illustrate the issues encountered by Editors and Authors at each of these stages of the publication process.

Advocacy Discussion: 3.40pm – 4.40pm 

Dr Fiona Measham, Professor of Criminology in the School of Applied Social Sciences (Durham University UL)

Dr Marianne Jauncey, Medical Director Uniting Medically Supervised Injecting Centre (MSIC)

The purpose of this Workshop is to have an informal discussion regarding the importance of advocacy within the drug and alcohol field. Our speakers will discuss the successes, detractions, and lessons they’ve learnt in their own advocacy undertakings. Discussions will also focus on how advocacy can sit alongside, and be integrated as part of, a research career.

This section of the workshop will be facilitated by two of our conference keynotes with a track record of advocacy work.

When:

Sunday 12 November
5.30pm – 7.45pm

5:30pm:Drinks & Canapés
6:00pm:Session starts
7:15pm:Drinks and canapés
7:45: Close

Cost:

Free and open to the public (not just conference delegates)

Presenters:

First Speaker: TBC

Second Speaker: Dr James Bell - Buprenorphine dose response: Safety and Efficacy in Clinical Trials

Third Speaker: TBC

Overview: